Digestive System Diseases: News and Research on Deglutition Disorders

MeSH tree: C06.405.117.119

FDA approves Voquezna for erosive esophagitis, GERD

The U.S. Food and Drug Administration has approved Phathom Pharmaceuticals' Voquezna (vonoprazan), a novel potassium-competitive acid blocker, as a new treatment for adults for with all grades of erosive esophagitis or erosive ...

Revisional-RYGB examined for GERD and weight-loss failure

Following sleeve gastrectomy (SG), revisional Roux-Y-gastric-bypass (RYGB) is beneficial for remission of reflux symptoms and extra weight loss, according to a study published online Aug. 18 in Obesity Surgery.

page 8 from 13